Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
141.85B | 124.20B | 97.78B | 93.08B | 90.55B | 100.33B | Gross Profit |
29.52B | 25.81B | 19.79B | 20.40B | 20.57B | 20.47B | EBIT |
8.81B | 6.76B | 5.00B | 5.69B | 5.66B | 8.05B | EBITDA |
12.05B | 11.13B | 8.19B | 8.39B | 8.57B | 9.78B | Net Income Common Stockholders |
3.27B | 2.67B | 4.21B | 8.17B | 958.00M | 5.70B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
24.62B | 30.04B | 23.26B | 29.06B | 34.13B | 23.03B | Total Assets |
188.16B | 208.01B | 146.46B | 153.57B | 144.12B | 128.34B | Total Debt |
28.05B | 38.14B | 19.09B | 27.76B | 27.60B | 14.14B | Net Debt |
3.42B | 10.54B | -4.17B | -1.30B | -6.30B | -8.88B | Total Liabilities |
81.39B | 102.48B | 63.78B | 72.63B | 72.33B | 60.98B | Stockholders Equity |
89.30B | 87.35B | 81.18B | 79.50B | 70.47B | 66.07B |
Cash Flow | Free Cash Flow | ||||
0.00 | -8.37B | 5.82B | -14.04B | 5.86B | -3.72B | Operating Cash Flow |
0.00 | -5.63B | 8.23B | 812.00M | 10.08B | 3.64B | Investing Cash Flow |
0.00 | -2.77B | -2.82B | -5.37B | -4.45B | -8.05B | Financing Cash Flow |
0.00 | 7.44B | -11.56B | -628.00M | 7.32B | -2.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥4.63T | 17.49 | 9.61% | 2.02% | 10.92% | 4.32% | |
75 Outperform | ¥912.70B | 11.21 | 9.99% | 3.87% | -2.46% | -12.73% | |
74 Outperform | ¥579.54B | 28.55 | 6.03% | 1.58% | 5.12% | 43.96% | |
71 Outperform | ¥71.20B | 10.20 | 6.22% | 4.72% | 11.07% | 53.83% | |
68 Neutral | €188.70B | 8.46 | 8.48% | 4.53% | 4.18% | 51.04% | |
66 Neutral | ¥87.15B | 13.27 | 3.79% | 34.77% | -13.32% | ||
64 Neutral | $4.39B | 11.81 | 5.20% | 249.38% | 3.96% | -12.36% |